Ignite Creation Date:
2025-12-24 @ 4:06 PM
Ignite Modification Date:
2026-02-22 @ 9:04 AM
Study NCT ID:
NCT00541866
Status:
COMPLETED
Last Update Posted:
2018-01-09
First Post:
2007-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans
Sponsor:
Sunesis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10-06
Start Date Type:
ACTUAL
Primary Completion Date:
2012-02-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-08
First Submit QC Date:
None
Study First Post Date:
2007-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-31
Results First Submit QC Date:
None
Results First Post Date:
2018-01-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-11
Last Update Post Date:
2018-01-09
Last Update Post Date Type:
ACTUAL